Gene-drug interaction screens in cancer

Add to your list(s) Download to your calendar using vCal

• Sebastian Nijman (Ludwig Institute for Cancer Research Oxford)
• Monday 16 May 2016, 16:00-17:00
• CRUK CI Room 215A/B.

If you have a question about this talk, please contact Florian Markowetz.

With the complete molecular characterization of the major cancer types in sight, it is clear that only a minority of the cancer genes represent readily accessible drug targets. Furthermore, mechanistic biomarkers that predict response to targeted therapies remain scant. We employ large-scale chemical genetic screens in isogenic cells to systematically uncover gene-drug interactions in cancer. In this seminar, I will present recently published and unpublished work uncovering unexpected gene-drug interactions with potential clinical relevance. I will also present our recent efforts to employ systematic reverse genetic screens using high throughput RNA -seq in arrayed collections of CRISPR /Cas9 edited cell lines.

This talk is part of the Seminars on Quantitative Biology @ CRUK Cambridge Institute series.

This talk is included in these lists:

• All CMS Events
• All Talks (aka the CURE list)
• Biology
• CCC talks for website
• CRUK CI Room 215A/B
• CRUK CI Seminars
• CamBridgeSens
• Cambridge Centre for Data-Driven Discovery (C2D3)
• Cambridge talks
• Chris Davis' list
• Computational and Systems Biology
• Graduate-Seminars
• Interested Talks
• Liam
• Life Science Interface Seminars
• Life Sciences
• Life Sciences
• ME Seminar
• PMRFPS's
• School of Physical Sciences
• Seminars on Quantitative Biology @ CRUK Cambridge Institute
• Trust & Technology Initiative - interesting events
• bld31
• custom
• my_list
• ndk22's list
• ob366-ai4er
• other talks
• rp587
• se393's list
• sfm36

Note that ex-directory lists are not shown.